EuroQuity Blog

Join the next Belgian E-Pitch session on December 10th at 5:00 PM CET

Introducing 5 Belgian companies looking for tickets between 0,5 M and 17 M EUR.

HoHoho… Christmas is coming…What would you ask this year from Santa? What would you put on your wish list?

 No doubt, the wishes to Santa Claus will be a little bit different compared to previous years. However, one thing we are pretty much certain of is that all startups looking for funds would love to see their current fundraising closed by the end of the year. Maybe this year you could be their Santa 🎅 !?

As we want to help you with that, we've selected 5 great companies to join this last EuroQuity e-pitch session of 2020. Together, these five companies are looking for €28M. If you want to discover more, register now for the session and offer these startups their Best Christmas ever!

Register now

The selection is as follows:
BioTech - Antiviral Therapies
The company is harnessing its VHH technology platform to generate antiviral therapies providing broad protection against viral infections. It is a spin out from VIB, based on the work of Professor Drs Xavier Saelens and Nico Callewaert. XVR011, its lead compound for treatment and prophylaxis of COVID-19, is a VHH linked to an effector function silenced Fc which neutralizes against viral infection by binding to the RBD of the spike protein of SARS-CoV-2. It has a broad coverage, cross-reactive with SARS-CoV-1, SARS COV-2 and another bat coronavirus, binds to a highly conserved epitope and is expected to be less prone to genetic pressure to mutate.
CMC collaboration with UCB Belgium for process development and manufacture of GMP material for first clinical trial. Phase 1b planned in Q1 2021. It raised 23M earlier this year, backed by blue chip investors led by Fund+, VIB, UCB Ventures, SFPI-FPIM, V-Bio and several Belgian Family Offices and is now looking to raise an additional 17M as its progresses into the clinic. Next Step: clinical trial | 17M€ sought

Industry | Artificial Intelligence
With high-tech privacy, accuracy and precision, the company develops next-generation decision making technology in finance, energy, security, defense, and healthcare domains. Hybrid Core It navigates decision makers via strategic foresight and intelligent dash boarding platforms by providing advanced data analytics and multiple future scenarios simulations. One of their projects, SmartNavigator —in partnership with the New Jersey Institute of Technology— is awarded by the EU Commission. Another project, AI-Powered Advanced Red Teaming (APART)—in partnership with Embry-Riddle Aeronautical University—  was accredited by the US Homeland Security ecosystem at a high-level international summit. Accordingly, the company has credible R&D partners in Europe and the US, and renown names in their advisory board. Their uniqueness stems from innovative methodologies for high accuracy and full privacy, reusable models and technology, and hybrid intelligence.  The company is a game-changer and frontier in the algorithmic decision systems.
Strong human capital, Academia & industry partnership, Extensive network and credibility | Next Step: Product ready and market entry | 2M€ sought
Digital - Food Delivery
Finally an ethical alternative compared to Deliveroo and Uber Eats! The delivery sector has been booming for the past ten years and its growth is accelerating during the Covid period. The company developped a platform offering a better service for both restaurants and customers at a lower price compared to the 2 main players that dominate the market. The start-up has managed to capture the market, is growing rapidly and has already engaged the best restaurants in the city.
Solution operational, restaurants are signing up. Next step: optimize logistics and entry French market (Paris) | 500k€ sought
HealthTech | Next generation sleep apnea solutions
Medical Device company transforming patient diagnosis and treatment for sleep apnea, a highly prevalent sleep disorder with close to 1 billion persons concerned. Company has developed a 3-gram sensor to diagnose sleep apnea from home, with unprecedented clinical results.  It is the only certified medical device with fully automated analysis demonstrating agreement over 90% with in-lab sleep studies, at a fraction of the cost. Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems. The sensor is also part of a no-surgery therapy, with clinical results equal to latest implanted devices. A solution for the 35% patients non-compliant with current standard of care.
Technology is close to reimbursement with a Forfait Innovation to start in 2021 in France (600k sleep tests per year) |Next Step: acceptance for reimbursement | 5M€ sought

PropTech | Real Estate Franchisor
The scale-up is a real estate franchisor active in the residential sector which offers products & services to its real estate agencies. In order to save time and gain in efficiency, they digitize and optimize the whole workflow processes of a real estate agency and they optimize the entire residential real estate transactions lifecycle. Basically, they help our real estate agencies be more efficient so their agents can focus on what they do best which is managing the human, relational & commercial aspects of a transaction, in order to drive more sales and grow faster.
>80 collaborators & 4,2M€ turnover / Exclusive residential partner with BNP Paribas Real Estate | Series A of 4M€ launched (75% are already secured), <1M€ soughts
Only registrants will receive via email:
  • The day of the pitch: the access link
  • The day after the pitch: the EuroQuity links of the companies that pitched.
We look forward to seeing you all on December 10 at 5 p.m.

You receive this invitation because you are registered as an investor on the Euroquity site or because you are in our databases. To unsubscribe, please send a request to

Rédigé par Cristina Chumacero le Monday, November 30th 2020
Stay informed by suscribing to our newsletter